Clinic for Medical Oncology, Department for Gastrointestinal and Lung Cancers, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.
J Adolesc Young Adult Oncol. 2023 Apr;12(2):207-214. doi: 10.1089/jayao.2021.0230. Epub 2022 Jun 22.
Early-onset colorectal cancer (CRC) is a growing problem. The aim of the study was to identify adolescent and young adult (AYA) patients with CRC in Serbia, treated in the single tertiary cancer center. This is a retrospective study that included only AYA patients (ages 18-39 years) with histologically confirmed CRC. In 11 year (2009-2019), 109 patients were identified from a single-institution database and their clinical variables and outcomes were analyzed. The prevalence of a positive family history of CRC was 12.8%. Presenting symptoms were not different than traditional CRC. More than a quarter were diagnosed as an emergency. Left-sided tumors were diagnosed in 83.4% and mucinous tumors were recorded in one-third of the patients. Postoperatively patients mainly were in PS0-1 (97%). Patients presented as stages II (18.3%), III (47.7%), and IV (33.9%). The recurrence rate in local stages was 50%. Surgical treatment of localized metastatic disease was performed in almost half of the stage IV patients. Median disease-free survival for patients with the recurrent disease was 11.8 months. Median overall survival (OS) for the local and metastatic stage was 64.3 and 20.5 months, respectively. Survival analysis showed that performance status, bowel obstruction, N2 status, local invasions, disease stage, and surgery in stage IV had a statistically significant influence on OS. Serbian AYA CRC patients are of good general condition, with advanced left-sided tumors, common mucinous histology, and inverse histology features. Surgery in metastatic disease provided long-term survival. The outcome of the patient is influenced by a late diagnosis, inverse histological features, and treatment provided.
早发性结直肠癌(CRC)是一个日益严重的问题。本研究旨在确定在塞尔维亚单一三级癌症中心接受治疗的青少年和年轻成人(AYA)CRC 患者。这是一项回顾性研究,仅纳入经组织学证实为 CRC 的 AYA 患者(年龄 18-39 岁)。在 11 年(2009-2019 年)期间,从单一机构数据库中确定了 109 名患者,并分析了他们的临床变量和结局。CRC 阳性家族史的患病率为 12.8%。主要表现症状与传统 CRC 无差异。超过四分之一的患者被诊断为急症。左半结肠癌诊断占 83.4%,三分之一的患者记录有黏液性肿瘤。术后患者主要处于 PS0-1(97%)。患者分期为 II 期(18.3%)、III 期(47.7%)和 IV 期(33.9%)。局部复发率为 50%。近一半的 IV 期患者接受了局部转移性疾病的手术治疗。复发性疾病患者的无病生存期中位数为 11.8 个月。局部和转移性分期的总生存期(OS)中位数分别为 64.3 个月和 20.5 个月。生存分析显示,功能状态、肠梗阻、N2 状态、局部侵犯、疾病分期和 IV 期手术对 OS 有统计学显著影响。塞尔维亚 AYA CRC 患者一般状况良好,左半结肠癌多见,常见黏液组织学特征,组织学特征相反。转移性疾病的手术可提供长期生存。患者的预后受到晚期诊断、相反的组织学特征和所提供的治疗的影响。